TSX:TH (Theratechnologies)
About TH
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
Theratechnologies (TSX: TH) Latest News
Tech Stocks
How I’d Allocate $14,000 in Tech Stocks in Today’s Market
Investing
2 Biotech Stocks to Buy Before the Down Market Recovers
Page
Top Biotech Stocks in Canada of 2026
Investing
Value Stocks: 1 Cheap Healthcare Company for TFSA Investors
Investing
Healthcare Stocks Are up an Insane 37.9% in 2021
Investing
1 Small-Cap Biotech Stock for High-Risk Canadian Investors
Investing
2 TSX 30 Growth Stocks With Returns That Will Make Your Jaw Drop
Tech Stocks
The Best Canadian Stock to Buy Right Now!
Investing
3 High-Growth Stocks That Can Boost Your TFSA to New Heights
Dividend Stocks
4 Stocks That Are Absurdly Cheap Right Now
Dividend Stocks
Forget Big Oil Stocks: 1 Aggressive Strategy for Young Investors
Investing
3 Reasons This Biotech Stock Could Double in 2019
1❯